The 10 October issue of the Canada Gazette (Part I) confirms that Ottawa has formally extended two emergency measures designed to keep Ebola out of the country. Order No. 2 Amending the “Minimizing the Risk of Exposure to Ebola Disease in Canada Order (Immigration Applications and Documents)” pushes the end-date of the suspension on finalising immigration documents for applicants who live in the Democratic Republic of the Congo, South Sudan or Uganda to 23:59 EST on 27 November 2026. A parallel Transport Canada Interim Order continues to bar anyone who has been in the DRC within the previous 21 days from boarding a flight to Canada. The immigration order blocks the final approval of permanent-resident visas, temporary-resident visas, electronic travel authorisations, work permits and study permits for affected applicants. It also suspends any such documents that were previously issued, generating an automatic “no-board” message in airline systems. Exemptions remain possible on humanitarian or public-health grounds, but they are issued case-by-case by the Minister of Immigration. From a corporate-mobility perspective, the extension means multinational employers must continue to delay travel or relocation plans that involve talent based in the three African countries. Employers planning inter-company transfers, training rotations or conference travel should move affected staff to a third country well in advance, or explore virtual alternatives, to avoid last-minute refusals. Travel-risk teams should also note that the Quarantine Act order mandating 21-day quarantine for travellers arriving from the DRC, South Sudan or Uganda remains in force. Why this matters: The decision highlights how quickly public-health concerns can override normal immigration processing. Companies with operations or supply chains in Central and East Africa should review emergency-mobility contingency plans, paying particular attention to document validity and flight routings. Although Ebola vaccines exist for Zaire-strain outbreaks, there is still no approved vaccine for the Bundibugyo strain driving the current DRC epidemic, so more extensions are possible.
Source: Canada Gazette (Part I)
